These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16556497)

  • 1. Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.
    Essink-Bot ML; Rijnsburger AJ; van Dooren S; de Koning HJ; Seynaeve C
    Breast; 2006 Oct; 15(5):673-6. PubMed ID: 16556497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
    Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
    Kuhl C; Weigel S; Schrading S; Arand B; Bieling H; König R; Tombach B; Leutner C; Rieber-Brambs A; Nordhoff D; Heindel W; Reiser M; Schild HH
    J Clin Oncol; 2010 Mar; 28(9):1450-7. PubMed ID: 20177029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
    Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
    Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of women with familial risk of breast cancer.
    Boetes C
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):97-101. PubMed ID: 12585662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
    J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and specific distress in women at intermediate and high risk of breast cancer before and after surveillance by magnetic resonance imaging and mammography versus standard mammography.
    Brédart A; Kop JL; Fall M; Pelissier S; Simondi C; Dolbeault S; Livartowski A; Tardivon A;
    Psychooncology; 2012 Nov; 21(11):1185-94. PubMed ID: 21812069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of magnetic resonance imaging in breast cancer screening.
    Lee CH; Weinreb JC
    J Am Coll Radiol; 2004 Mar; 1(3):176-82. PubMed ID: 17411555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception of care and experience of examination in women at risk of breast cancer undergoing intensive surveillance by standard imaging with or without MRI.
    Brédart A; Kop JL; Fall M; Pelissier S; Simondi C; Dolbeault S; Livartowski A; Tardivon A;
    Patient Educ Couns; 2012 Mar; 86(3):405-13. PubMed ID: 21795009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast self-examination also valuable in women participating in a screening programme].
    Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI screening in a clinic population with a family history of breast cancer.
    Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
    Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2003 Australian Breast Health Survey: survey design and preliminary results.
    Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
    BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are women with functional limitations at high risk of underutilization of mammography screening?
    Ahmed NU; Smith GL; Haber G; Belcon MC
    Womens Health Issues; 2009; 19(1):79-87. PubMed ID: 19111790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).
    Kuhl CK
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI in breast cancer management: potential for benefit and harm.
    Jatoi I
    Int J Fertil Womens Med; 2005; 50(6):281-4. PubMed ID: 16526420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):391-402, vii. PubMed ID: 17098180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].
    van Asperen CJ; de Bock GH; van der Horst F; de Koning HJ; Rutgers EJ
    Ned Tijdschr Geneeskd; 2001 Jan; 145(3):120-5. PubMed ID: 11206121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MRI for breast disease diagnosis; an asset, but the proper place has to be determined first].
    Wobbes T
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1490-2. PubMed ID: 16032991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.